Cooper Simon Peter 4
4 · Keros Therapeutics, Inc. · Filed Aug 11, 2021
Insider Transaction Report
Form 4
Cooper Simon Peter
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-08-10+60,000→ 60,000 totalExercise: $34.98Exp: 2031-08-09→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest twenty-five percent (25%) on August 2, 2022, and six and one-quarter percent (6.25%) of such shares shall vest at the end of each successive three (3) month period thereafter, subject to the Reporting Person continuing to provide service through each such date.